Exhibit 99.1 McKESSON CORPORATION REPORTS FISCAL 2026 THIRD QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EPS GUIDANCE IRVING, Texas, February 4, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the third quarter ended December 31, 2025. Third Quarter Highlights: Fiscal 2026 Full Year Outlook: "McKesson delivered another strong quarter, extending the momentum we've built across the enterprise and demonstrating the impact of our disciplined execution," said Brian Tyler, chief executive offi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q RESERVOIR MEDIA, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 83-3584204 (I.R.S. Employer Identification No.) (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...

Exhibit 99.1 Accuray Reports Fiscal 2026 Second Quarter Financial Results MADISON, Wis, February 4, 2026 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights "Over the past 90 days, I've met extensively with Accuray teams and customers across all major regions. Their insights have directly informed the decisive actions we've already taken — from reorganizing our commercial structure to refining our near‑term product and service ...

Financial Performance - Net sales for Q4 2025 were $774.3 million, a 19% increase from $651.0 million in Q4 2024[4] - GAAP net income for Q4 2025 was $50.7 million, or $0.48 per diluted share, compared to $5.2 million, or $0.05 per diluted share in Q4 2024[5] - Adjusted EBITDA for Q4 2025 was $126.2 million, representing 16.3% of net sales, up from $95.7 million, or 14.7% of net sales in Q4 2024[6] - Full year 2025 net sales increased to $2.9 billion, a 19% rise from $2.4 billion in 2024[8] - Non-GAAP net income for Q4 2025 reached $74.8 million, or $0.70 per diluted share, an all-time quarterly record high[9] - Total net sales reached $774.3 million in Q4 2025, up from $651.0 million in Q4 2024, and full-year net sales increased to $2.91 billion from $2.44 billion[27] - GAAP net income for Q4 2025 was $50.7 million, significantly higher than $5.2 million in Q4 2024, with full-year GAAP net income increasing to $177.4 million from $56.3 million[30] Margins and Profitability - Gross margin improved to 21.4% in Q4 2025 from 19.4% in Q4 2024, and full-year gross margin increased to 20.7% from 19.5%[27] - Operating margin significantly increased to 10.4% in Q4 2025 compared to 1.4% in Q4 2024, with full-year operating margin rising to 9.1% from 4.8%[27] - Non-GAAP gross profit for Q4 2025 was $167.8 million, up from $133.2 million in Q4 2024, with a non-GAAP gross margin of 21.7% compared to 20.5%[28] - Non-GAAP operating income for Q4 2025 was $98.2 million, up from $65.8 million in Q4 2024, with a non-GAAP operating margin of 12.7% compared to 10.1%[28] - Adjusted EBITDA for Q4 2025 was $126.2 million, an increase from $95.7 million in Q4 2024, with an adjusted EBITDA margin of 16.3% compared to 14.7%[30] Cash Flow and Restructuring - The company reported a cash flow from operations of $62.9 million, or 8.1% of net sales for Q4 2025[9] - Free cash flow for Q4 2025 was $11.7 million, down from $33.3 million in Q4 2024, while full-year free cash flow decreased to $17.9 million from $84.0 million[30] - The company reported a restructuring charge of $216, down from $4.8 million in Q4 2024, indicating improved operational efficiency[27] Market and Future Outlook - The total book-to-bill ratio for Q4 2025 was 1.35, indicating strong order growth[9] - For Q1 2026, TTM estimates net sales will be between $770 million and $810 million, with non-GAAP net income projected at $0.64 to $0.70 per diluted share[14] - The Data Center Computing and Networking end markets accounted for 36% of total company revenues, driven by demand for generative AI[9] - TTM's total assets as of December 29, 2025, were $3.84 billion, an increase from $3.47 billion in 2024[26] Segment Performance - Aerospace & Defense segment net sales grew to $318.0 million in Q4 2025 from $306.2 million in Q4 2024, with full-year sales rising to $1.29 billion from $1.14 billion[27]

Financial Performance - For the three months ended December 31, 2025, net revenue was $48.931 million, a decrease of 28% compared to $67.762 million for the same period in 2024[18] - Gross profit for the six months ended December 31, 2025, was $74.026 million, down from $92.290 million in 2024, reflecting a gross margin decline[18] - Operating income for the three months ended December 31, 2025, was $487 thousand, significantly lower than $3.428 million in the same period of 2024[18] - Net income for the three months ended December 31, 2025, was $276 thousand, compared to $2.550 million for the same period in 2024, indicating a substantial decline[18] - The company reported a net income per share of $0.02 for the three months ended December 31, 2025, down from $0.21 in the same period of 2024[18] - As of December 31, 2025, LifeVantage reported a net income of $2,431,000, a decrease of 44.5% compared to $4,376,000 for the same period in 2024[26] - The company experienced a net cash provided by operating activities of $486,000 for the six months ended December 31, 2025, significantly lower than $8,616,000 for the same period in 2024[26] - For the three months ended December 31, 2025, net income was $276,000, compared to $2.55 million for the same period in 2024[60] - Basic net income per share for the three months ended December 31, 2025, was $0.02, down from $0.21 in 2024[60] - The net income for the three months ended December 31, 2025, was $276,000, down from $2,550,000 in the prior year, reflecting a decline of approximately 89%[95] Assets and Liabilities - Total current assets decreased to $38.557 million as of December 31, 2025, down from $50.894 million as of June 30, 2025[17] - Total liabilities decreased to $28.182 million as of December 31, 2025, compared to $37.317 million as of June 30, 2025[17] - The total stockholders' equity as of December 31, 2025, was $32.987 million, a decrease from $34.641 million as of June 30, 2025[17] - Total long-lived assets as of December 31, 2025, were reported at $21,895,000, an increase from $20,819,000 as of June 30, 2025[96] Inventory and Cash Management - Total inventory as of December 31, 2025, was $18,978,000, down from $20,669,000 as of June 30, 2025, reflecting a reduction in inventory values of $2.9 million related to obsolete and slow-moving inventory[40] - Cash and cash equivalents at the end of the period were $10,181,000, a decrease from $21,595,000 at the end of December 2024[26] - The company repurchased $577,000 worth of its stock during the six months ended December 31, 2025, compared to $1,114,000 in the same period of 2024[26] - The company experienced a foreign currency translation adjustment loss of $259 thousand for the three months ended December 31, 2025[18] - The company reported a foreign currency effect on cash of $(205,000) for the six months ended December 31, 2025[26] Operational Challenges and Future Outlook - The company anticipates ongoing challenges in managing supply chain pressures and attracting new customers, which may impact future performance[11] Acquisition and Related Costs - The Company completed the acquisition of LoveBiome on October 1, 2025, for a total purchase price of $4,243,000, which includes $3,743,000 in cash consideration[101][104] - The acquisition of LoveBiome is expected to enhance the Company's offerings in microbiome care and wellness solutions, with goodwill from the acquisition estimated at $522,000[105] - The Company incurred acquisition-related costs of approximately $34,000 during the three months ended December 31, 2025, related to the LoveBiome transaction[108] - The estimated earnout related to the LoveBiome acquisition was adjusted to $200,000 as of December 31, 2025, reflecting lower than forecasted revenue performance[107] - Total revenue and net income of LoveBiome from the date of acquisition to December 31, 2025, were not material to the Company's consolidated financial statements[110] Stock and Compensation - During the three months ended December 31, 2025, the Company issued 0.1 million shares of common stock under stock plans, consistent with the same period in 2024[76] - Cash dividends for the three months ended December 31, 2025, totaled $0.6 million, compared to $0.5 million in the same period of 2024, representing a 20% increase[83] - The Company has reserved a total of 0.8 million shares for issuance under the 2019 Employee Stock Purchase Plan, with 0.4 million shares available as of December 31, 2025[88] - Stock-based compensation for the three months ended December 31, 2025, was $0.6 million, a decrease of 64.7% from $1.7 million in the same period of 2024[91] - LifeVantage's stock-based compensation expense was $1,379,000 for the six months ended December 31, 2025, down from $2,639,000 in the same period of 2024[26] Lease and Operating Expenses - Operating lease expense for the three months ended December 31, 2025, was $0.5 million, the same as in 2024[66] - Total lease expense for the three months ended December 31, 2025, was $469,000, a decrease of 7.1% from $505,000 in the same period of 2024[67] - Operating cash outflows from operating leases for the six months ended December 31, 2025, were $1,088,000, down from $1,129,000 in 2024, reflecting a decrease of 3.6%[67] - The weighted average remaining lease term for operating leases was 5.63 years as of December 31, 2025[65] Tax and Accounting Changes - The company recognized income tax expense of $0.2 million for the three months ended December 31, 2025, down from $0.5 million in 2024[57] - The company has early adopted ASU 2025-06 for the current fiscal year, impacting the accounting for internal-use software[63] - The company recorded an increase of $33,000 in contract liabilities impact to revenue for the three months ended December 31, 2025[46] - Deferred revenue related to contract liabilities was $0.7 million as of December 31, 2025, unchanged from June 30, 2025[46] - The returns liability reserve, net, was $0.2 million as of December 31, 2025, consistent with the previous period[47] Revenue Breakdown - The United States accounted for $36,738,000 of total revenue for the three months ended December 31, 2025, representing 75% of total revenue, while Japan contributed $6,278,000[96] - Major product lines, including Protandim, TrueScience, and LifeVantage, accounted for approximately 78.1% of total net revenue for the three months ended December 31, 2025[97] - The Company has identified two major markets, the United States and Japan, which each exceed 10% of consolidated total revenue[96]

Financial Performance - Lesaka reported Q2 FY2026 revenue of $178.734 million, a slight increase of 1.4% year-on-year compared to $176.216 million in Q2 FY2025[3] - Net revenue for Q2 FY2026 was $93.403 million, representing a 16% increase from $77.060 million in Q2 FY2025[3] - Operating income surged to $2.150 million, a 265% increase from $547,000 in the same quarter last year[3] - The company achieved a positive net income of $3.645 million, a significant turnaround from a loss of $32.456 million in Q2 FY2025[3] - Group Adjusted EBITDA for Q2 FY2026 was $17.777 million, up 47% from $11.580 million in Q2 FY2025[3] - Lesaka reported a GAAP net income of $3,645 for the three months ended December 31, 2025, compared to a loss of $32,456 in the same period of 2024, marking a significant turnaround[28] - The company's Group Adjusted EBITDA for the six months ended December 31, 2025, was $32,872, up from $20,719 in the prior year, reflecting a 58.5% increase[28] - Net Revenue for the three months ended December 31, 2025, was $93,403, representing a 21.3% increase from $77,060 in the same period of 2024[32] - Adjusted net income for the six months ended December 31, 2025, was $11,085, compared to $2,551 in the same period of 2024, reflecting a substantial increase[35] Future Guidance - Lesaka reaffirmed its full-year guidance for FY2026, projecting a 49% growth in Group Adjusted EBITDA at the mid-point[5] - For Q3 FY2026, Lesaka expects net revenue between ZAR 1.65 billion and ZAR 1.80 billion[6] - The company anticipates Group Adjusted EBITDA for Q3 FY2026 to be between ZAR 300 million and ZAR 340 million[6] - FY2026 guidance includes net revenue expectations of ZAR 6.4 billion to ZAR 6.9 billion and adjusted earnings per share of at least ZAR 4.60, indicating over 100% year-on-year growth[14] Segment Performance - The Merchant segment revenue for the three months ended December 31, 2025, was $131,919, down from $145,209 in the same period of 2024, indicating a decline of 9.0%[32] - The Enterprise segment revenue for the three months ended December 31, 2025, increased to $14,796 from $8,933 in the prior year, showing a growth of 65.5%[33] Assets and Liabilities - Total current assets as of December 31, 2025, were R 4,723,610, an increase from R 4,330,950 as of June 30, 2025[41] - Total liabilities as of December 31, 2025, were R 7,097,257, slightly down from R 7,036,164 as of June 30, 2025[41] Transaction Costs and Acquisitions - The company incurred transaction costs related to acquisitions totaling $373 for the six months ended December 31, 2025, compared to $537 in the same period of 2024[29] - The company incurred transaction costs related to acquisitions amounting to R 805 for the three months ended December 31, 2025, down from R 3,957 in 2024[38] - Lesaka's acquisition of Bank Zero is pending regulatory approvals and will not impact the FY2026 guidance[7] Fair Value Changes - The company reported a change in fair value of equity securities of R 50,000 for the three months ended December 31, 2025, compared to a loss of R 614,710 in 2024[38] Exchange Rates - The exchange rate for USD to ZAR was 16.9556 for the three months ended December 31, 2025, compared to 17.8495 in 2024[38]

Exhibit 99.1 Coherent Corp. 375 Saxonburg Blvd. Saxonburg, PA 16056-9499 PRESS RELEASE COHERENT CORP. REPORTS SECOND QUARTER FISCAL 2026 RESULTS SAXONBURG, Pa., February 4, 2026 (GLOBE NEWSWIRE) – Coherent Corp. (NYSE: COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, announced financial results today for its second quarter of fiscal year 2026 ended December 31, 2025. Revenue for the second quarter of fiscal 2026 was $1.69 billion, with GAAP gross margin of 36.9% and GAAP net income ...

Financial Performance - Q4'25 total revenues reached $1,047.6 million, up 5.2% sequentially and 5.3% year-over-year[4] - Q4'25 Clear Aligner revenues were $838.1 million, reflecting a 4.0% sequential increase and a 5.5% year-over-year increase[4] - FY2025 total revenues were $4.0 billion, with Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $789.6 million, representing increases of 0.9%, 0.5%, and 2.7% year-over-year, respectively[3] - Net revenues for Q4 2025 were $1,047,561, compared to $995,219 in Q4 2024, marking an increase of approximately 5.3%[29] - GAAP net revenues for 2025 were $4,034,964 thousand, a slight increase from $3,999,012 thousand in 2024, representing a growth of 0.9%[35] - Clear Aligner net revenues for 2025 were $3,245,404 thousand, up from $3,230,122 thousand in 2024, indicating a growth of 0.5%[35] Profitability - Q4'25 gross profit was $683.6 million, resulting in a gross margin of 65.3%[5] - Q4'25 net income was $135.8 million, or $1.89 per diluted share, with a non-GAAP net income of $236.0 million, or $3.29 per diluted share[5] - Gross profit for the year ended December 31, 2025, was $2,711,013, down from $2,799,159 in 2024[29] - GAAP gross profit for Q4 2025 was $683,587 thousand, compared to $696,941 thousand in Q4 2024, a decrease of 1.9%[36] - The constant currency gross margin for Q4 2025 was 64.8%, down from 70.0% in Q4 2024, reflecting a decline of 5.2 percentage points[36] - Non-GAAP gross profit for the three months ended December 31, 2025, was $754,727, compared to $705,152 in 2024, with a non-GAAP gross margin of 72.0% versus 70.9%[40] Operational Metrics - Q4'25 Clear Aligner volumes totaled 676.9 thousand cases, up 4.5% sequentially and 7.7% year-over-year[2] - In FY2025, 935.8 thousand teens and kids started treatment with Invisalign clear aligners, up 7.8% year-over-year[6] - The number of Invisalign trained doctors in Q4 2025 was 87,710, slightly down from 85,685 in Q4 2024, a decrease of 2.4%[32] - The average Clear Aligner revenue per case shipment in Q4 2025 was $1,240, down from $1,265 in Q4 2024, a decline of 2.0%[32] Future Guidance - Q1'26 worldwide revenues are expected to be in the range of $1,010M to $1,030M, representing a year-over-year increase of 3% to 5%[17] - Q1'26 Clear Aligner volume is anticipated to grow in the mid-single digits year-over-year[17] - Q1'26 GAAP operating margin is projected to be between 12.4% and 12.8%, with a Non-GAAP operating margin of approximately 19.5%[17] - For fiscal year 2026, worldwide revenue growth is expected to be up 3% to 4% year-over-year[17] - The 2026 GAAP operating margin is expected to be slightly below 18.0%, with a 400 basis points improvement over 2025[17] Shareholder Actions - During Q4'25, the company repurchased approximately 0.7 million shares at an average price of $142.87, completing a $200 million repurchase plan[12] Strategic Initiatives - The company launched the Invisalign System with mandibular advancement in Thailand and the Philippines, addressing Class II correction[13] - The company aims to expand international adoption and increase orthodontic utilization, particularly among teens and kids, as part of its strategic priorities for 2026[10] Cash Flow and Assets - Net cash provided by operating activities decreased to $593,223 thousand in 2025 from $738,231 thousand in 2024, a decline of 19.7%[31] - Total assets increased to $6,233,693 thousand in 2025 from $6,214,600 thousand in 2024, reflecting a growth of 0.3%[30] - Total stockholders' equity increased to $4,049,147 thousand in 2025 from $3,851,985 thousand in 2024, a growth of 5.1%[30] - Total current liabilities decreased to $1,920,015 thousand in 2025 from $2,038,027 thousand in 2024, a reduction of 5.8%[30] Cost Structure and Expenses - The company initiated restructuring plans to reduce headcount and increase efficiencies, impacting operating expenses and overall cost structure[42] - Stock-based compensation for the year ended December 31, 2025, amounted to $185,870, up from $173,703 in 2024[42] - Stock-based compensation is projected to account for approximately 5.0% in Q1 2026 and 5.1% in fiscal 2026[45][46] - Amortization of intangibles is estimated to be around 0.5% for both Q1 2026 and fiscal 2026[45][46] - Depreciation on assets disposed of other than by sale is expected to be approximately 1.3% to 1.5% in Q1 2026 and 0.3% to 0.4% in fiscal 2026[45][46] Impairment and Losses - The company recorded an impairment loss related to a manufacturing facility classified as assets held for sale during Q3 2025[44] - An impairment loss for obsolete inventory was also recorded in Q3 2025[44] - Costs related to the disposal of certain manufacturing fixed assets were recorded in Q4 2025[44]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to _________ Commission file number: 001-38312 _________________ 8x8, INC. (Exact name of Registrant as Specified in its Charter) ___________ ...

Financial Performance - Net sales for Q4 2025 decreased by 0.8% year over year to $702.9 million, while gross billings increased by 2.9% to $1.1 billion[3] - Gross profit for Q4 2025 rose by 4.5% to $135.6 million, with gross margin increasing by 100 basis points to 19.3%[5] - Net income for Q4 2025 remained flat at $20.7 million, translating to diluted EPS of $0.82, up from $0.78 in Q4 2024[3] - For the full year 2025, net sales increased by 2.5% to $2.9 billion, with gross billings rising by 2.7% to $4.1 billion[10] - Adjusted diluted EPS for Q4 2025 was $0.91, compared to $0.78 for Q4 2024, reflecting a significant year-over-year increase[3] - Net income for the year ended December 31, 2025, was $83,722,000, down from $87,095,000 in 2024[29] - Net income for Q4 2025 was $20,712, a slight decrease of 0% compared to $20,721 in Q4 2024, and total net income for the year was $83,722, down 4% from $87,095 in 2024[33] - Adjusted Net Income for Q4 2025 rose by 11% to $23,063 from $20,721 in Q4 2024, with total Adjusted Net Income for the year at $88,149, a 2% increase from $86,142[36] Segment Performance - The Business Solutions segment saw a 4.2% increase in net sales to $273.5 million in Q4 2025, while the Public Sector Solutions segment experienced a 36.8% decline to $90.8 million[11] - Enterprise Solutions net sales rose to $338,662,000 with a gross margin of 14.2%, compared to $302,711,000 and 14.9% in the previous year[28] Cash and Liquidity - Cash and cash equivalents as of December 31, 2025, were $406.7 million, down from $442.6 million a year earlier[9] - Cash and cash equivalents increased to $193,221,000 from $178,318,000 year-over-year[30] - Cash flows provided by operating activities for Q4 2025 were $27,418, compared to $25,248 in Q4 2024, with total cash flows for the year at $65,438, significantly down from $173,868[31] - The company declared a quarterly dividend of $0.20 per share, with a total of $81.2 million available for future share repurchases[2] Shareholder Actions - The company repurchased 179,235 shares at an aggregate price of $10.7 million during Q4 2025[9] Expenses and Other Income - The company reported a significant increase in severance expenses, totaling $3,083 in Q4 2025, compared to none in Q4 2024, reflecting restructuring activities[36] - The company recorded $1.7 million in other income from a legal settlement, impacting the financial results positively[34] - Total depreciation and amortization expenses for Q4 2025 were $2,850, a 10% decrease from $3,166 in Q4 2024[33] Operational Metrics - Inventory turns decreased to 18 from 23, indicating a slower inventory turnover rate[26] - Days sales outstanding increased to 76 days from 72 days, reflecting a longer collection period for receivables[26] - Total assets increased to $1,350,925,000 from $1,299,354,000 year-over-year[30] Earnings Per Share - Diluted earnings per share increased by 5% to $0.82 from $0.78 year-over-year[26] - Diluted Earnings per Share for Q4 2025 increased by 5% to $0.82 compared to $0.78 in Q4 2024, while Adjusted Diluted Earnings per Share rose by 16% to $0.91 from $0.78[36] EBITDA - Adjusted EBITDA for the year ended December 31, 2025, increased by 6% to $126.4 million compared to $118.9 million in 2024[13] - Adjusted EBITDA for Q4 2025 increased by 13% to $31,771 compared to $28,083 in Q4 2024, while the last twelve months (LTM) Adjusted EBITDA was $126,417, up 6% from $118,936[33] Interest Income - The company experienced a 25% decrease in interest income, reporting $(3,591) in Q4 2025 compared to $(4,779) in Q4 2024[33]